Member Info for lignumvitae

The money may well have been raised for all the right reasons but that doesn't stop the sour taste. Very nice being an institution - "aha - here is a nice little pharma company, seems to be very undervalued. OK - let's offer to buy some new shares at a 20% discount. What about the existing shareholders? Those mugs - don't bother about them mate" There needs to be a mechanism for pre-emption without the inordinate costs of a Rights Issue. As it stands pre-emption rights are little more than a Dodo.

The interims today are good news in the sense that they contain no nasty surprises. Construction remains on track as does the target of revenue generation commencing in December. The monsoon season is over with no negative weather related events. This ship is nearly ready to set sail with a captain and crew that appear to be up to the task. The construction investment at completion will be a multiple of the current market cap. It's been a long wait but this stock seems to be ready to deliver the goods.

I am expecting solid results & a positive outlook on 27 Sept. This stock, in my opinion, has been sold down way too far. After all it s one month after a discounted placing of ordinary at 160 & issue of convertible with conversion price of 200. An opportunity to accumulate a holding in a company which could very produce significant returns.

Looking at recent trades and SP's it seems to me highly likely that a small company fund is assembling a holding.

First it marched to the top of the hill - then it marched down again & now it is on the up once again. Why ? Well it is a thinnish market and the speed of the ascent was so sudden it brought out the sellers. I still believe that the patient holders who do not try to trade in and out will be very well rewarded over time.

John Teeling is a company boss who always has the interests of shareholders in mind. If he is excited by the kimberlite discovery then a modest degree of excitement from shareholders is warranted. Diamonds within the kimberlite is likely to result is a quantum leap for the shares. Speculative so not one to bet your shirt on but certainly worth a few of the buttons.

Read this announcement & the notes very carefully before committing funds. This debt raising from directors indicates an element of desperation. Also what the heck are "anti dilution warrants" exercisable at 1 pence ? How and when do these kick in ? This may well be an excellent business in time but it may be that the share price will plumb new depths before the potential is realised. BEWARE !!

I said that "value" was stripped and it was. The shares were trading at £1.40 before the announcement. Yes, the price was depressed but note: Wandisco spent a long time in the dog-house before fighting its way back. After all, if every company who's share price spends time in the doldrums, decided, in a fit of petulence, tt delist, then very soon there would't be a stockmarket. As for NASDAQ there would have been no difficulty, at any time, in seeking a quote in addition to the AIM quote. People do not forget actions like this. For instance - if Standard Life had been considering the GIANT product would they, after being stung on their shareholding, be more or less amenable to signing up ?

I have only one last thing to say about Fusionex & that any reputable exchange should consider very carefully before welcoming any company with which Ivan Teh is associated. There was no good reason for the delisting. If the company had continued to win contracts & increase profits then this, in due course would have been recognised. To simply strip shareholders of value on a whim is unacceptable. Indeed the LSE rules on delisting are appallingly weak & leave shareholders open to this kind of practice. That it can be done pretty much by the vote of the majority shareholder & at such speed leaves an unpleasant odour.

RNS this morning. CEO Leigh Nissim resigns. Re trading it is reported that growth continues but not quantified - ie NOT "strong growth". Refinancing discussions reported as advanced but i would be surprised if any equity raise were at a premium to current price. Also if less than 27p the earlier capital raise gets repriced.

On 31 March we were told to expect the refinancing in the "coming weeks" but that there were "material uncertainties" over the successful conclusion of such refinancing. Well, we are now coming up to 10 weeks and still no announcement. One wonders just how "material" the uncertainties are. Caveat emptor!

I have written positively about this stock so am feeling bruised. What an extraordinary breach of faith. This type of behavior with its self serving excuses should not be allowed by the LSE & should be voted down by shareholders. OK Standard Life - lets see you take the lead.

Just like a bright kid with lego this company is patiently building something quite impressive. We have seen some weakness following the sales of shares issued to the creditors of Prolong and some vendor sales but now these have been digested the share price can resume its upwards trend. Not too late tu buy or add.

Do you remember Dana? Such a boring stock & named after an Irish folk singer. Well, Tom Cross had the last laugh and delivered stellar returns to patient holders. Now he is doing it all over again at Parkmead [a company that sounds more like a retirement hole in Bournemouth!]. There is stable & growing gas production in the Netherlands which provides cash flow. Meanwhile he is consolidating very attractive interests in the North Sea & Shetland areas. The company is capitalised at £48m at the current price of 48p and has some £25m in the bank. Therefore you get an awful lot for your money. One to buy & hold and, hopefully, watch your investment grow from a bright youngster into a fine and prosperous adult. Maybe it will then finance the costs of that care home in Bournemouth!

I think the reason that it continues to rise is that the historic and prospective PE's remain undemanding. Also there seem to be few sellers. This stock has been 'under the radar' and is only now being appreciated. I feel this is a stock to buy & hold - not to attempt to trade.

Sit tight and hold on for potential significant long term gains

What I like about a stock is when I see capable & adept management & an aversion to dilution. The sales channel is clearly going to be weighted to etailers and on-line/TV shopping channels. Yesterday an astute acquisition of a device for treating PE & today an announcement of a tie-up with ASOS and a very positive trading statement. The ASOS deal re Skinny Tan indicates that if all goes well Stevie K and Marshall + Lee could also find a sales channel via ASOS in due course. Still a modest market cap & an interesting and expanding stable of products. Time will tell but there is clear potential for rapid sales & profit growth and a share price two or three years out of a multiple of the current price.

This trust has a very nice portfolio of investments. The NAV is on an impressive upwards curve. The shares are on something like a 20% discount. So far, so good, so boring you might say. BUT: There are SUBSCRIPTION SHARES exercisable at 915p up to end June. They are just on the money and are at a mid price of 12.5p and can probably be bought at the mid. Setting of a limit is essential. For the gambler a continuing bullish market & a narrowing of the discount could provide short term strong percentage returns. Not for the fainthearted & pin money only but maybe a better bet than the 3.30 at Kempton Park.

Only came across this company with the recent announcement. Looked at it quite closely and am impressed with what I see. Nothing is guaranteed of course - no crystal ball ! However I believe that the potential is there for a significant increase in profitability and EPS with the consequent rerating.

The potential of this small but well managed business, on a low historic & prospective p/e and in an area of business with massive growth to come, is just starting to be recognised. Potential for much more share price appreciation.